% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

  • larshansson18 larshansson18 Jul 1, 2010 11:52 AM Flag

    One risk less: Financing is closed

    We now have a financed CO and some milstones during the fall. Some of them might give us a durable financing until cash flow from Ceplene is here.

    As for the shareprice it is under the price set in the PP and definitly under the dilution. After some selling from the ones who, from different preferences needs/wants to sell, there is room for a short increasing demand given the new price, Cet par.

    As I understood Talley on the webcast there are news coming strengthening the application on the question of overall survival.

    I can understand those who hesitate after the bloody monday. No time for heroism, niether way. But take a close look at this play, the substance is there and the upcoming cash-flow aswell.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.92+0.07(+3.78%)Mar 30 4:00 PMEDT